Quellios uses smartphone-based bio-optical technology to analyze fingertip signals following a meal to assess the body's inflammatory response. Users photograph their food and capture body signals to generate personalized response scores and identify dietary patterns affecting digestive wellness. This system provides real-time, non-invasive insights to help users understand how specific foods impact their physiology.
Funding
Funding not disclosed
Founders
Product
Problem
Current chronic care management and everyday well-being solutions often lack the precision and personalization required for effective health outcomes. This gap limits the ability to proactively address health challenges through continuous, data-driven insights.
Solution
Quellios is developing advanced wearable biosensing technology to provide personalized, physiological-data-driven insights for improved chronic care management and daily well-being. Leveraging patent-pending innovations in photoplethysmography (PPG) signal analysis and system engineering, the platform aims to deliver smarter, more effective sensing capabilities. The company's approach focuses on translating complex biometric data into actionable information that supports proactive health management and better health outcomes for individuals.
Target Audience
The primary target audience includes individuals managing chronic conditions and those seeking to enhance their daily well-being through personalized health monitoring.
Features
- Patent-pending wearable biosensing technology for continuous physiological data acquisition.
- Advanced photoplethysmography (PPG) signal processing for motion-tolerant and accurate biometric readings.
- System engineering expertise focused on low-power medical diagnostics and real-time physiological monitoring.
- Development of personalized insights derived from collected biometric data to support chronic care and well-being.
- Focus on translating sensor technology into practical health solutions for improved health outcomes.